(81 days)
Not Found
No
The summary describes a non-invasive therapeutic device that uses electromagnetic fields and a touch screen interface for setting parameters. There is no mention of AI, ML, image processing, or any data-driven learning capabilities. The performance studies focus on electrical safety standards compliance.
Yes
The device description explicitly states, "The BTL 799-2T is a non-invasive therapeutic device."
No
The "Intended Use / Indications for Use" section describes the device's purpose as muscle strengthening, toning, and firming, which are therapeutic rather than diagnostic actions. There is no mention of the device being used to detect, identify, or monitor any medical condition.
No
The device description explicitly states it is a "non-invasive therapeutic device" that "produces electromagnetic field" and has "two outputs enable simultaneous treatment by two applicators." It also mentions a "large color touch screen" and setting "therapeutic parameters." These are all descriptions of hardware components and their functions, not solely software.
Based on the provided information, the BTL 799-2T is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly states that the device is used for improving muscle tone and strengthening in specific anatomical areas (abdomen, buttocks, thighs, arms). This is a therapeutic use, not a diagnostic one.
- Device Description: The description states it's a "non-invasive therapeutic device" that produces an electromagnetic field to interact with human tissue. This aligns with a physical therapy or aesthetic treatment device, not a device that analyzes samples from the body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), performing tests on these samples, or providing diagnostic information about a patient's health condition.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The BTL 799-2T does not fit this description.
N/A
Intended Use / Indications for Use
BTL 799-2T is indicated to be used for:
· Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
· Strengthening, Toning and Firming of buttocks and thighs.
· Improvement of muscle tone and firmness, for strengthening muscles in arms.
Product codes
NGX
Device Description
The BTL 799-2T is a non-invasive therapeutic device. The device produces electromagnetic field that interacts with the tissues of the human body. The device two outputs enable simultaneous treatment by two applicators.
The BTL 799-2T is equipped with a large color touch screen with wide view angle that significantly facilitates the use of the device. The on-screen information guides the user stepby-step through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen of the device. During the therapy the device keeps information about the applied therapy type, remaining therapy time and main therapy parameters on the screen.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
abdominal, buttocks, thighs, arms
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 890.5850 Powered muscle stimulator.
(a)
Identification. A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 23, 2018
BTL Industries, Inc. David Chmel VP of Operations 362 Elm Street Marlborough, MA 01752
Re: K182106
Trade/Device Name: BTL 799-2T Regulation Number: 21 CFR 890.5850 Regulation Name: Powered Muscle Stimulator Regulatory Class: Class II Product Code: NGX Dated: July 31, 2018 Received: August 3, 2018
Dear David Chmel:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Vivek J. Pinto -S
for Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K182106
Device Name BTL 799-2T
Indications for Use (Describe)
BTL 799-2T is indicated to be used for:
· Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
· Strengthening, Toning and Firming of buttocks and thighs.
· Improvement of muscle tone and firmness, for strengthening muscles in arms.
| Type of Use (Select one or both, as applicable) |
|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) |
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three nested squares with the letters "BTL" inside, followed by the text "BTL Industries" in a sans-serif font. The squares and text are a dark blue-gray color, and the background is white.
510(k) Summary
General Information
| Sponsor: | BTL Industries, Inc.
362 Elm Street
Marlborough, MA 01752
Tel: +1-866-285-1656
Fax: +1-888-499-2502 |
|------------------------------|-----------------------------------------------------------------------------------------------------------------|
| Applicant: | BTL Industries, Inc.
362 Elm Street
Marlborough, MA 01752
Tel: +1-866-285-1656
Fax: +1-888-499-2502 |
| Contact Person: | David Chmel
BTL Industries, Inc.
chmel@btlnet.com |
| Summary Preparation
Date: | October 02, 2018 |
Device Name
| Trade/Proprietary Name: | BTL 799-2T |
|---|---|
| Primary Classification Name: | Stimulator, Muscle, Powered |
| Classification Regulation: | 21 CFR 890.5850, Class II |
| Classification Product Code: | NGX |
Legally Marketed Predicate Devices
The BTL 799-2T is a state-of-the-art electromagnetic device with accessories, and is substantially equivalent to the current products that are already cleared for distribution in the USA under the following 510(k) Premarket Notification number:
4
Image /page/4/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected blue diamond shapes on the left, with the letters "BTL" inside the diamonds. To the right of the diamond shapes, the words "BTL Industries" are written in a gray, sans-serif font.
Product Description
The BTL 799-2T is a non-invasive therapeutic device. The device produces electromagnetic field that interacts with the tissues of the human body. The device two outputs enable simultaneous treatment by two applicators.
The BTL 799-2T is equipped with a large color touch screen with wide view angle that significantly facilitates the use of the device. The on-screen information guides the user stepby-step through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen of the device. During the therapy the device keeps information about the applied therapy type, remaining therapy time and main therapy parameters on the screen.
Intended Use
BTL 799-2T is indicated to be used for:
- . Improvement of abdominal tone, strengthening of the abdominal muscles, development of firmer abdomen.
- Strengthening, Toning and Firming of buttocks and thighs.
- . Improvement of muscle tone and firmness, for strengthening muscles in arms.
Non-clinical Testing
The BTL 799-2T device has been thoroughly evaluated for electrical safety. The device has been found to comply with the following applicable medical device safety standards:
| IEC 60601-1 | Medical electrical equipment – Part 1: General requirements for basic
safety and essential performance |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IEC 60601-1-2 | Medical electrical equipment – Part 1-2: General requirements for
basic safety and essential performance - Collateral standard:
Electromagnetic disturbances - Requirements and tests |
| IEC 60601-1-6 | Medical electrical equipment – Part 1-6: General requirements for
basic safety and essential performance - Collateral standard: Usability |
| IEC 60601-2-10 | Medical Electrical Equipment – Part 2-10: Particular Requirements for
the Basic Safety and Essential Performance of Nerve and Muscle
Stimulators |
5
Image /page/5/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected blue squares on the left side, with the letters "BTL" visible within the squares. To the right of the squares, the words "BTL Industries" are written in a dark gray, sans-serif font.
| IEC 62366 | Medical devices - Application of usability engineering to medical
devices |
|--------------|---------------------------------------------------------------------------------------------------------------|
| IEC 62304 | Medical device software – Software life cycle processes |
| ISO 14971 | Medical devices – Application of risk management to medical devices |
| ISO 10993-1 | Biological evaluation of medical devices – Part 1: Evaluation and
testing within a risk management process |
| ISO 10993-5 | Biological evaluation of medical devices – Part 5: Tests for in vitro
cytotoxicity |
| ISO 10993-10 | Biological evaluation of medical devices – Part 10: Tests for irritation
and skin sensitization |
Technological Characteristics
The BTL 799-2T device is technologically identical to the primary predicate device BTL 799-2 (K180813). The BTL 799-2T device and its predicates are comprised of a system console and applicator(s). The system console consists of the electromagnetic field generators, computer, and the touch-screen control panel.
Generated electromagnetic field is intended to interact with the tissues of the human body to achieve muscle stimulation.
The technological similarities and differences between the BTL 799-2T device and the predicate devices are described bellow in the comparison table. The differences do not raise any new types of safety or effectiveness questions.
| 510(k) number | Not Assigned | K180813 | K092476 |
|---|---|---|---|
| Device name | BTL 799-2T | BTL 799-2 | Body Control System |
| "4M" | |||
| Company name | BTL Industries, Inc. | BTL Industries, Inc. | SPORT-ELEC S.A. |
| Product Code | |||
| and Regulation | Physical Medicine | ||
| 21 CFR 890.5850 | |||
| NGX - Stimulator, Muscle, | |||
| Powered, Muscle | |||
| Conditioning | Physical Medicine | ||
| 21 CFR 890.5850 | |||
| NGX - Stimulator, Muscle, | |||
| Powered, Muscle | |||
| Conditioning | Physical Medicine | ||
| 21 CFR 890.5850 | |||
| NGX - Stimulator, Muscle, | |||
| Powered, Muscle | |||
| Conditioning | |||
| 510(k) number | Not Assigned | K180813 | K092476 |
| Device name | BTL 799-2T | BTL 799-2 | Body Control System |
| "4M" | |||
| Company name | BTL Industries, Inc. | BTL Industries, Inc. | SPORT-ELEC S.A. |
| Intended Use | BTL 799-2T is indicated to | ||
| be used for: | |||
| • Improvement of | |||
| abdominal tone, | |||
| strengthening of the | |||
| abdominal muscles, | |||
| development of firmer | |||
| abdomen. | |||
| • Strengthening, Toning | |||
| and Firming of buttocks | |||
| and thighs. | |||
| • Improvement of muscle | |||
| tone and firmness, for | |||
| strengthening muscles | |||
| in arms. | BTL 799-2 is indicated to be | ||
| used for: | |||
| • Improvement of | |||
| abdominal tone, | |||
| strengthening of the | |||
| abdominal muscles, | |||
| development of firmer | |||
| abdomen. | |||
| • Strengthening, Toning | |||
| and Firming of buttocks | |||
| and thighs. | Body Control System 4M is | ||
| indicated for the | |||
| improvement of muscle tone | |||
| and firmness, for | |||
| strengthening muscles in | |||
| arms, abdomen, thighs and | |||
| buttocks areas. | |||
| Contraindicated use on | |||
| injured or otherwise | |||
| impaired muscles | |||
| Not intended for use in any | |||
| therapy or for the treatment | |||
| of any medical conditions or | |||
| diseases | |||
| Principle of Action | Initiating action potential of | ||
| nerves results in muscle | |||
| contraction | Initiating action potential of | ||
| nerves results in muscle | |||
| contraction | Initiating action potential of | ||
| nerves results in muscle | |||
| contraction | |||
| Clinical Use | Prescription use | Prescription use | Over-the-counter use |
| Electrical | |||
| Protection | Class II, BF | Class II, BF | Class II, BF |
| User Interface | Touch screen | Touch screen | LCD screen |
| Firmware | |||
| Controlled | Yes | Yes | Yes |
| Type of Energy | Magnetic field | Magnetic field | Electrical |
| Number of outputs | 2 | 2 | 2 |
| Number of | |||
| Magnetic Coils | |||
| in the Applicator | 1 | 1 | N/A |
| Magnetic Field | |||
| Intensity | 299-6 applicator: 0.5-1.8 T | 299-6 applicator: 0.5-1.8 T | N/A |
| 510(k) number | Not Assigned | K180813 | K092476 |
| Device name | BTL 799-2T | BTL 799-2 | Body Control System |
| "4M" | |||
| Company name | BTL Industries, Inc. | BTL Industries, Inc. | SPORT-ELEC S.A. |
| Pulse Repetition | |||
| Rate | 1 - 150 Hz | 1 – 150 Hz | 0,25-160 Hz |
| Pulse Duration | 280 ± 20% µs | 280 ± 20% µs | 70 - 360 µs |
| Selection of | |||
| parameters | |||
| (Intensity, Time) | Yes | Yes | Yes |
| Therapy Time | Up to 60 min | Up to 60 min | Up to 40 min |
| Energy Source | 100 - 240 V AC, 50-60 Hz | 100 - 240 V AC, 50-60 Hz | 3.7 V Rechargeable battery |
| pack | |||
| System | |||
| Dimensions | |||
| (W×H×D) | 500×1380×580 mm | ||
| (20×55×23 in) | 500×1380×580 mm | ||
| (20×55×23 in) | 84x126x30xmm | ||
| (3x5x1 in) | |||
| Ambient | |||
| Temperature | -10°C to +55°C | -10°C to +55°C | 0°C to +45°C |
| Relative Humidity | 10% to 85% | 10% to 85% | 10% to 90% |
| Environmental | |||
| Specifications | For indoor use only | For indoor use only | For indoor use only |
Comparison with the Predicate Device
6
Image /page/6/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three nested squares, each rotated 45 degrees, with the letters "BTL" inside. To the right of the square logo is the text "BTL Industries" in a gray, sans-serif font.
7
Image /page/7/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected blue squares on the left side, with the letters "B", "T", and "L" inside each square, respectively. To the right of the squares is the text "BTL Industries" in a dark gray, sans-serif font.
Substantial Equivalence
The technological characteristics of the BTL 799-2T device are identical to the primary predicate BTL 799-2 and substantially equivalent to the secondary predicate Body Control System "4M".
The BTL 799-2T technology is already cleared. It is using mechanism of neuromuscular stimulation by the current induced in the tissue. The subject device induced current of 28-30 mA is identical to the primary predicate. The already cleared device areas of application are abdomen, buttocks and thighs muscles. The same type of mechanism of action is applied to the same type muscles newly also in area of arms. Since only the application area is being extended, the difference does not rise any new questions of safety and effectiveness.
The main difference between BTL 799-2T and secondary predicate Body Control System "4M" is in the energy type used to stimulate the tissues. The BTL 799-2T device is inducing stimulation current by magnetic field, the Body Control System "4M" is stimulating
8
Image /page/8/Picture/0 description: The image shows the logo for BTL Industries. The logo consists of three interconnected blue squares, each containing the letters "BTL" in white. To the right of the square logo is the text "BTL Industries" in a dark gray sans-serif font. The overall design is clean and modern.
neuromuscular tissue via the direct current flow. In both cases there is an induction of electrical stimulus in the neuromuscular tissue which represents identical mechanism of action. Therefore this difference does not rise any new questions of safety and effectiveness.
The differences between the predicate devices and BTL 799-2T device have no significant influence on safety or effectiveness of the BTL 799-2T device. Therefore, the BTL 799-2T device is substantially equivalent to the predicate devices.
Conclusion
Based upon the intended use and known technical information provided in this pre-market notification, the BTL 799-2T device has been shown to be substantially equivalent to currently marketed predicate devices.